PALM COAST, Fla. — Designs for Health, a leading practitioner-recommended supplement brand, has launched Anaerostipes Probiotic, the first dietary supplement to feature Anaerostipes caccae CLB101™, a next-generation probiotic strain developed by ClostraBio.
Unlike conventional probiotics, the new formulation is designed to deliver direct butyrate production, enhance microbiome diversity, and strengthen the gut barrier. Butyrate, a short-chain fatty acid produced by microbial fermentation, is essential for fueling colonocytes—the cells that line the gut—while supporting immune function and overall digestive resilience.*
“Anaerostipes is not just another probiotic, it's a leap forward in gut health innovation,” said Dr. David M. Brady, Chief Medical Officer at Designs for Health. “By reintroducing a keystone organism like Anaerostipes caccae CLB101™, we're able to influence the entire microbial environment in a way that supports barrier function, immune regulation, and metabolic signaling, the core pillars of long-term GI health.”
The probiotic works by converting excess lactate into butyrate, addressing challenges associated with poorly metabolized D-lactate, while also crossfeeding other beneficial microbes to promote long-term gut balance. Delivered in a once-daily capsule, Anaerostipes Probiotic targets four key areas: microbiome diversity, gut barrier integrity, digestive comfort, and regularity.
The launch comes at a time when consumer interest in probiotics is surging—about one-third of consumers actively seek probiotic products, with 60% consuming them daily, according to industry data.
“The launch of Anaerostipes reflects our unwavering commitment to advancing the science of nutrition and delivering real solutions that address the root causes of health challenges,” said Amardeep Kahlon, Chief Executive Officer at Designs for Health. “As a brand built on clinical integrity and innovation, we strive to equip practitioners with cutting-edge tools that improve patient outcomes and redefine what's possible in functional medicine.”
“With its focus on innovative, science-backed ingredients and leadership role in the functional medicine space, Designs for Health was the obvious partner to commercialize the first dietary supplement containing our next-generation Anaerostipes caccae CLB101™ ingredient”, noted Ritu Shah, CEO of ClostraBio. “Designs for Health has the team and the experience required to educate both health-care practitioners and consumers on the important role for both CLB101™ and butyrate in gut health.”
Anaerostipes Probiotic is now available at designsforhealth.com.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
